|
Oncogenes and Tumor Suppressors
Citations 341-350 of 795 total displayed.
|
Past content
(since May 2000):
|
Global approach to the diagnosis of leukemia using gene expression profiling
- Torsten Haferlach, Alexander Kohlmann, Susanne Schnittger, Martin Dugas, Wolfgang Hiddemann, Wolfgang Kern, and Claudia Schoch
Blood 2005; 106: 1189-1198.
[Abstract]
[Full text]
[PDF]
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes
- David P. Steensma, Gordon W. Dewald, Terra L. Lasho, Heather L. Powell, Rebecca F. McClure, Ross L. Levine, D. Gary Gilliland, and Ayalew Tefferi
Blood 2005; 106: 1207-1209.
[Abstract]
[Full text]
[PDF]
Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a
- Bin Zhang, John Groffen, and Nora Heisterkamp
Blood 2005; 106: 1355-1361.
[Abstract]
[Full text]
[PDF]
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)
- Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, Julian Schardt, Myriam Eyer, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, and Thomas Pabst
Blood 2005; 106: 1369-1375.
[Abstract]
[Full text]
[PDF]
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
- Giovanni Cazzaniga, Maria Grazia Dell'Oro, Cristina Mecucci, Emanuela Giarin, Riccardo Masetti, Vincenzo Rossi, Franco Locatelli, Massimo F. Martelli, Giuseppe Basso, Andrea Pession, Andrea Biondi, and Brunangelo Falini
Blood 2005; 106: 1419-1422.
[Abstract]
[Full text]
[PDF]
The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM
- Kent S. Boles, Winfried Barchet, Tom Diacovo, Marina Cella, and Marco Colonna
Blood 2005; 106: 779-786.
[Abstract]
[Full text]
[PDF]
RNA interference in biology and disease
- Carol A. Sledz and Bryan R. G. Williams
Blood 2005; 106: 787-794.
[Abstract]
[Full text]
[PDF]
Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation
- Marianna Shafarenko, Dan A. Liebermann, and Barbara Hoffman
Blood 2005; 106: 871-878.
[Abstract]
[Full text]
[PDF]
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas
- Cristiana Bellan, Stefano Lazzi, Michael Hummel, Nazzareno Palummo, Margherita de Santi, Teresa Amato, Joshua Nyagol, Elena Sabattini, Thierry Lazure, Stefano A. Pileri, Martine Raphael, Harald Stein, Piero Tosi, and Lorenzo Leoncini
Blood 2005; 106: 1031-1036.
[Abstract]
[Full text]
[PDF]
Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states
- Keitarou Doi, Xiaolin Wu, Yuko Taniguchi, Jun-ichirou Yasunaga, Yorifumi Satou, Akihiko Okayama, Kisato Nosaka, and Masao Matsuoka
Blood 2005; 106: 1048-1053.
[Abstract]
[Full text]
[PDF]
|
|
